We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Calls Trial Data Transparency Draft Policy Balanced and Fair
EMA Calls Trial Data Transparency Draft Policy Balanced and Fair
June 27, 2014
The European Medicines Agency is pushing back against critics who accuse it of softening its commitment to clinical trials data transparency, saying there has been “absolutely no change in direction” in the agency’s efforts to make trial data more publicly available.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor